INS and COVID-19: Seventy-one (57.7%) patients had IR; there was no evidence of an association between IR and mortality from severe or critical COVID-19, and so were gender, comorbidities, insulin <10.3 IU/L, lymphopenia, or hypoalbuminemia (Table 2).